Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov 1;80(5):633-635.
doi: 10.1097/FJC.0000000000001338.

Anti-Inflammatory Therapy for Acute Coronary Syndromes: Is It Time for a Shift in the Treatment Paradigm?

Affiliations
Comment

Anti-Inflammatory Therapy for Acute Coronary Syndromes: Is It Time for a Shift in the Treatment Paradigm?

Martino Pepe et al. J Cardiovasc Pharmacol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

G. Biondi-Zoccai has consulted for Cardionovum, Crannmedical, Innovheart, Guidotti, Meditrial, Opsens Medical, Replycare, Teleflex, and Terumo. The remaining authors report no conflicts of interest.

Comment on

References

    1. Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling . Nat Rev Cardiol. 2014. 11:255–265.
    1. Huang S, Frangogiannis NG. Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges . Br J Pharmacol. 2018. 175:1377–1400.
    1. Schmidt M, Lamberts M, Olsen AM, et al. Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology . Eur Heart J. 2016. 37:1015–1023.
    1. Arslan F, Smeets MB, O'Neill LA, et al. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody . Circulation. 2010. 121:80–90.
    1. Toldo S, Austin D, Mauro AG, et al. Low-density lipoprotein receptor-related protein-1 is a therapeutic target in acute myocardial infarction . JACC Basic Transl Sci. 2017. 2:561–574.

MeSH terms

Substances